Christopher Yea
CHIEF DEVELOPMENT OFFICER · 7 filings · Latest: Jun 11, 2026
KalVista Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KALV | Christopher Yea | CHIEF DEVELOPMENT OFFICER | May 27, 2026 | Sale | $26.78 | 33,800 | $905.2K | 229,918 | |
KALV | Christopher Yea | CHIEF DEVELOPMENT OFFICER | May 27, 2026 | Option Exercise | $7.07 | 33,800 | $239.0K | 263,718 | |
KALV | CHRISTOPHER M YEA | — | May 27, 2026 | Proposed Sale | $26.78 | 33,800 | $905.2K | — | |
KALV | Christopher Yea | CHIEF DEVELOPMENT OFFICER | May 26, 2026 | Sale | $26.78 | 1,966 | $52.6K | 229,918 | |
KALV | Christopher Yea | CHIEF DEVELOPMENT OFFICER | May 22, 2026 | Option Exercise | — | 3,125 | — | 231,884 | |
KALV | Christopher Yea | CHIEF DEVELOPMENT OFFICER | May 22, 2026 | Sale | $26.78 | 2,358 | $63.2K | 228,759 | |
KALV | Christopher Yea | CHIEF DEVELOPMENT OFFICER | May 21, 2026 | Option Exercise | — | 3,750 | — | 231,117 | |
KALV | Christopher Yea | CHIEF DEVELOPMENT OFFICER | May 18, 2026 | Sale | $26.76 | 1,108 | $29.7K | 227,367 | |
KALV | Christopher Yea | CHIEF DEVELOPMENT OFFICER | May 17, 2026 | Option Exercise | — | 1,774 | — | 228,475 | |
KALV | Christopher Yea | CHIEF DEVELOPMENT OFFICER | Feb 23, 2026 | Sale | $15.57 | 4,347 | $67.7K | 226,701 | |
KALV | Christopher Yea | CHIEF DEVELOPMENT OFFICER | Feb 22, 2026 | Option Exercise | — | 3,125 | — | 231,048 | |
KALV | Christopher Yea | CHIEF DEVELOPMENT OFFICER | Feb 21, 2026 | Option Exercise | — | 3,750 | — | 227,923 | |
KALV | Christopher Yea | CHIEF DEVELOPMENT OFFICER | Feb 18, 2026 | Sale | $15.00 | 1,109 | $16.6K | 224,173 | |
KALV | Christopher Yea | CHIEF DEVELOPMENT OFFICER | Feb 17, 2026 | Option Exercise | — | 1,774 | — | 225,282 |